Clinical Trial Update: Study of Cemiplimab - TP Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck [Phase 1]

View source ↗

Summary

This Phase 1 trial is evaluating cemiplimab in combination with TP induction chemotherapy for locally advanced head and neck squamous cell carcinoma and is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cemiplimab (Libtayo) (cemiplimab)

Snippet

Sponsor: Krzysztof Misiukiewicz | Conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 1 | Status: ENROLLING_BY_INVITATION